πŸ‡ΊπŸ‡Έ FDA
Patent

US 11268145

Methods for treating Cushing's syndrome

granted A61KA61K31/4745A61K31/567

Quick answer

US patent 11268145 (Methods for treating Cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4745, A61K31/567, A61K31/573, A61K45/06